The U.S. has tested more than 26 million people for the coronavirus causing the disease COVID-19.
Read More...
Category - News
Donald Trump’s big campaign rally in Tulsa wasn’t quite as big as promised, with the man leading the president’s re-election efforts blaming the no-shows. But...
The stock-market’s ability to chug steadily higher despite uncertainty about how the economic recovery might shape up, and when the U.S. will bring the COVID...
The failure of the first fund to ever pay investors for their assets says more about the fund ecosystem than about customer penny-pinching, some observers...
Big shares of a losing biotech stock didn’t stop a pair of four-star-rated ETFs from moving higher Thursday. They may sound similar, but hold distinct...
Some of the money and investing stories popular with MarketWatch readers this past week.
Read More...
The information-technology and consumer-discretionary sectors were the top performers.
Read More...
Those betting against this “absurdly overvalued” stock market are about to get paid, if Kevin Smith, Crescat Capital’s chief investment officer, has it right...
The stock-market’s ability to chug steadily higher despite uncertainty about how the economic recovery might shape up, and when the U.S. will bring the COVID...
The economy snapped back in May after a two-month coronavirus lockdown, but make no mistake: The U.S. is still in a danger zone. Fresh viral outbreaks and...
